These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1519492)

  • 1. p53 expression in human breast cancer.
    Harris AL
    Adv Cancer Res; 1992; 59():69-88. PubMed ID: 1519492
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 mutations in breast cancer.
    Coles C; Condie A; Chetty U; Steel CM; Evans HJ; Prosser J
    Cancer Res; 1992 Oct; 52(19):5291-8. PubMed ID: 1394133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Li-Fraumeni syndrome].
    Alonso-Cerezo MC; Pérez-Pérez P
    Med Clin (Barc); 2011 Oct; 137(9):425-6. PubMed ID: 21345471
    [No Abstract]   [Full Text] [Related]  

  • 4. Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management.
    Moule RN; Jhavar SG; Eeles RA
    Fam Cancer; 2006; 5(2):129-33. PubMed ID: 16736281
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
    Menko FH; Nooy MA; Vasen HF
    Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1347-50. PubMed ID: 8710022
    [No Abstract]   [Full Text] [Related]  

  • 6. [Periodical screening of families with a hereditary predisposition for breast carcinoma].
    Vasen HF; Devilee P
    Ned Tijdschr Geneeskd; 1993 Nov; 137(46):2350-4. PubMed ID: 8264817
    [No Abstract]   [Full Text] [Related]  

  • 7. Inherited p53 gene mutations in breast cancer.
    Sidransky D; Tokino T; Helzlsouer K; Zehnbauer B; Rausch G; Shelton B; Prestigiacomo L; Vogelstein B; Davidson N
    Cancer Res; 1992 May; 52(10):2984-6. PubMed ID: 1581912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.
    Evans DG; Birch JM; Thorneycroft M; McGown G; Lalloo F; Varley JM
    J Med Genet; 2002 Dec; 39(12):941-4. PubMed ID: 12471212
    [No Abstract]   [Full Text] [Related]  

  • 9. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.
    Sherif ZA; Danielsen M
    Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Li-Fraumeni syndrome.
    Birch JM
    Eur J Cancer; 1994; 30A(13):1935-41. PubMed ID: 7734204
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
    Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM
    Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetics and cancer of the breast].
    Sobol H; Bignon YJ; Eisinger F; Birnbaum D; Fervers B
    Ann Chir; 1994; 48(4):303-8. PubMed ID: 8085754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.
    Bell DW; Varley JM; Szydlo TE; Kang DH; Wahrer DC; Shannon KE; Lubratovich M; Verselis SJ; Isselbacher KJ; Fraumeni JF; Birch JM; Li FP; Garber JE; Haber DA
    Science; 1999 Dec; 286(5449):2528-31. PubMed ID: 10617473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer in a 19-Year-Old Female Adolescent Identified with Li-Fraumeni Syndrome.
    Jay AM; Hamame AS; Dul C; Wesen C
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):e5-e6. PubMed ID: 27589880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
    Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first documentation of Li-Fraumeni syndrome in Korea.
    Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK
    J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges.
    Birch JM
    Br J Cancer; 1992 Sep; 66(3):424-6. PubMed ID: 1520579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.